1. Johnston SA. Osteoarthritis. Joint anatomy, physiology, and pathobiology. Vet Clin North Am Small Anim Pract 27:699-723, 1997. - PubMed -
2. Evans H. Miller’s Anatomy of the Dog, 3rd ed, 1993. - Available from amazon.com -
3. Poole CA, Flint MH, Beaumont BW. Chondrons in cartilage: ultrastructural analysis of the pericellular microenvironment in adult human articular cartilages. J Orthop Res 5:509-522, 1987. - PubMed -
4. Todhunter RJ, Johnston S. Osteoarthritis. Slatter’s Small Animal Surgery, 2003, pp. 2208-2245.
5. Eyre DR. Collagens and cartilage matrix homeostasis. Clin Orthop Relat Res 427:S118-122, 2004. - PubMed -
6. Cook. Proceedings of Veterinary Orthopedic Society, 2005; 41.
7. Todhunter RJ, Yeh LA, Sheldon A, et al. Effects of stromelysin activity on proteoglycan degradation of canine articular cartilage explants. Am J Vet Res 56:1241-1247, 1995. - PubMed -
8. Ghosh P, Smith M. The role of cartilage-derived antigens, pro-coagulant activity and fibrinolysis in the pathogenesis of osteoarthritis. Med Hypotheses 41:190-194, 1993. - PubMed -
9. Mankin HJ, Lippiello L. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. J Bone Joint Surg Am 52:424-434, 1970.
10. Setton LA, Zhu W, Mow VC. The biphasic poroviscoelastic behavior of articular cartilage: role of the surface zone in governing the compressive behavior. J Biomech 26:581-592, 1993. - PubMed -
11. Chalmers HJ, Dykes NL, Lust G, et al. Assessment of bone mineral density of the femoral head in dogs with early osteoarthritis. Am J Vet Res 67:796, 2006. - PubMed -
12. Manicourt DH, Altman RD, Williams JM, et al. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions. Arthritis Rheum 42:1159-1167, 1999. - PubMed -
13. Behets C, Williams JM, Chappard D, et al. Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency. J Bone Miner Res 19:1821-1826, 2004. - PubMed -
14. Ellison RS. The cytologic examination of synovial fluid. Semin Vet Med Surg (Small Anim) 3:133-139, 1988.
15. Fernandez FR, GC, Lipowitz AJ, et al. Synovial fluid analysis: preparation of smears for cytologic examination of canine synovial fluid. J Am Anim Hosp Assoc 727-734, 1983.
16. Pacchiana PD, Gilley RS, Wallace LJ, et al. Absolute and relative cell counts for synovial fluid from clinically normal shoulder and stifle joints in cats. J Am Vet Med Assoc 225:1866-1870, 2004. - PubMed -
17. Fox DB, Cook JL. Synovial fluid markers of osteoarthritis in dogs. J Am Vet Med Assoc 219:756-761, 2001. - PubMed -
18. Bruyere O, Collette JH, Ethgen O, et al. Biochemical markers of bone and cartilage remodeling in prediction of long term progression of knee osteoarthritis. J Rheumatol 30:1043-1050, 2003. - PubMed -
19. Otterness IG, Swindell AC, Zimmerer RO, et al. An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthr Cartilage 8:180-185, 2000. - PubMed -
20. Shiozawa K, Hino K, Shiozawa S. Alternatively spliced EDA-containing fibronectin in synovial fluid as a predictor of rheumatoid joint destruction. Rheumatology (Oxford) 40:739-742, 2001. - PubMed -
21. Claudepierre P, Allanore Y, Belec L, et al. Increased Ed-B fibronectin plasma levels in spondyloarthropathies: comparison with rheumatoid arthritis patients and a healthy population. Rheumatology (Oxford) 38:1099-1103, 1999. - PubMed -
22. Burton-Wurster N, Lust G. Deposition of fibronectin in articular cartilage of canine osteoarthritic joints. Am J Vet Res 46:2542-2545, 1985. - PubMed -
23. Steffey MA, Miura N, Todhunter RJ, et al. The potential and limitations of cartilage-specific (V+C)(-) fibronectin and cartilage oligomeric matrix protein as osteoarthritis biomarkers in canine synovial fluid. Osteoarthritis Cartilage 12:818-825, 2004.
24. Carnemolla B, Cutolo M, Castellani P, et al. Characterization of synovial fluid fibronectin from patients with rheumatic inflammatory diseases and healthy subjects. Arthritis Rheum 27:913-921, 1984. - PubMed -
25. Burton-Wurster N, Borden C, Lust G, et al. Expression of the (V+C)- fibronectin isoform is tightly linked to the presence of a cartilaginous matrix. Matrix Biol 17:193-203, 1998. - PubMed -
26. MacLeod JN, Burton-Wurster N, Gu DN, et al. Fibronectin mRNA splice variant in articular cartilage lacks bases encoding the V, III-15, and I-10 protein segments. J Biol Chem 271:18954-18960, 1996.
27. Burton-Wurster N, Chen H, Gendelman R, et al. Specific immunological detection of the (V+C)(-) fibronectin isoform. Matrix Biol 21:393-398, 2002. - PubMed -
28. Muller G, Michel A, Altenburg E. COMP (cartilage oligomeric matrix protein) is synthesized in ligament, tendon, meniscus, and articular cartilage. Connect Tissue Res 39:233-244, 1998.
29. Clark AG, Jordan JM, Vilim V, et al. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: The Johnston County Osteoarthritis Project. Arthritis Rheum 42:2356-2364, 1999.
30. Misumi K, Vilim V, Carter SD, et al. Concentrations of cartilage oligomeric matrix protein in dogs with naturally developing and experimentally induced arthropathy. Am J Vet Res 63:598-603, 2002. - PubMed -
31. Neidhart M, Hauser N, Paulsson M, et al. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 36:1151-1160, 1997. - PubMed -
32. Johnson KA, Hay CW, Chu Q, et al. Cartilage-derived biomarkers of osteoarthritis in synovial fluid of dogs with naturally acquired rupture of the cranial cruciate ligament. Am J Vet Res 63:775-781, 2002. - PubMed -
33. Belcher C, Yaqub R, Fawthrop F, et al. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees. Ann Rheum Dis 56:299-307, 1997. - PubMed -
34. Ratcliffe A, Shurety W, Caterson B. The quantitation of a native chondroitin sulfate epitope in synovial fluid lavages and articular cartilage from canine experimental osteoarthritis and disuse atrophy. Arthritis Rheum 36:543-551, 1993. - PubMed -
35. Visco DM, Johnstone B, Hill MA, et al. Immunohistochemical analysis of 3-B-(-) and 7-D-4 epitope expression in canine osteoarthritis. Arthritis Rheum 36:1718-1725, 1993. - PubMed -
36. Johnson KA, Hart RC, Chu Q, et al. Concentrations of chondroitin sulfate epitopes 3B3 and 7D4 in synovial fluid after intra-articular and extracapsular reconstruction of the cranial cruciate ligament in dogs. Am J Vet Res 62:581-587, 2001. - PubMed -
37. Hazell PK, Dent C, Fairclough JA, et al. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury. Arthritis Rheum 38:953-959, 1995. - PubMed -
38. Kuroki K, Cook JL, Kreeger JM. Effects of tissue inhibitor of metalloproteinases on canine chondrocytes cultured in vitro with tumor necrosis factor-alpha. Am J Vet Res 65:1611-1615, 2004. - PubMed -
39. Brama PA, TeKoppele JM, Beekman B, et al. Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid. Ann Rheum Dis 59:155-157, 2000. - PubMed -
40. Trumble TN, Trotter GW, Oxford JR, et al. Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses. Am J Vet Res 62:1467-1477, 2001.
41. Sandy JD. A contentious issue finds some clarity: on the independent and complementary roles of aggrecanase activity and MMP activity in human joint aggrecanolysis. Osteoarthritis Cartilage 14:95-100, 2006. - PubMed -
42. Lohmander LS, Hoerrner LA, Lark MW. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 36:181-189, 1993.
43. Cook JL, Anderson CC, Kreeger JM, et al. Effects of human recombinant interleukin-1beta on canine articular chondrocytes in three-dimensional culture. Am J Vet Res 61:766-770, 2000. - PubMed -
44. Spreng D, Sigrist N, Busato A, et al. Stromelysin activity in canine cranial cruciate ligament rupture. Vet Comp Orthop Traumatol 12:159-165, 1999.
45. Panula HE, Lohmander LS, Ronkko S, et al. Elevated levels of synovial fluid PLA2, stromelysin (MMP-3) and TIMP in early osteoarthrosis after tibial valgus osteotomy in young beagle dogs. Acta Orthop Scand 69:152-158, 1998. - PubMed -
46. Volk SW, Kapatkin AS, Haskins ME, et al. Gelatinase activity in synovial fluid and synovium obtained from healthy and osteoarthritic joints of dogs. Am J Vet Res 64:1225-1233, 2003. - PubMed -
47. Clegg PD, Burke RM, Coughlan AR, et al. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints. Equine Vet J 29:335-342, 1997. - PubMed -
48. Kealy RD, Lawler DF, Ballam JM, et al. Evaluation of the effect of limited food consumption on radiographic evidence of osteoarthritis in dogs. J Am Vet Med Assoc 217:1678-1680, 2000. - PubMed -
49. Breur G, et al. Genetics of hip dysplasia and other orthopedic traits. In: Ruvinsky and Sampson’s, The Genetics of the Dog. Oxford: CABI Publishing, 2001, p. 267.
50. Hardie EM. Management of osteoarthritis in cats. Vet Clin North Am Small Anim Pract 27:945-953, 1997. - PubMed -
51. Cooper C, Cushnaghan J, Kirwan JR, et al. Radiographic assessment of the knee joint in osteoarthritis. Ann Rheum Dis 51:80-82, 1992. - PubMed -
52. Morgan JP. Radiological pathology and diagnosis of degenerative joint disease in the stifle joint of the dog. J Small Anim Pract 10:541-544, 1969.
53. Innes JF, Costello M, Barr FJ, et al. Radiographic progression of osteoarthritis of the canine stifle joint: a prospective study. Vet Radiol Ultrasound 45:143-148, 2004. - PubMed -
54. Beale BS. Use of nutraceuticals and chondroprotectants in osteoarthritic dogs and cats. Vet Clin North Am Small Anim Pract 34:271-289, viii, 2004. - PubMed -
55. Impellizeri JA, Tetrick MA, Muir P. Effect of weight reduction on clinical signs of lameness in dogs with hip osteoarthritis. J Am Vet Med Assoc 216:1089-1091, 2000. - PubMed -
56. Kealy RD, Lawler DF, Ballam JM, et al. Five-year longitudinal study on limited food consumption and development of osteoarthritis in coxofemoral joints of dogs. J Am Vet Med Assoc 210:222-225, 1997. - PubMed -
57. Curtis CL, Hughes CE, Flannery CR, et al. n-3 Fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J Biol Chem 275:721-724, 2000. - PubMed -
58. Yoon JB, Kim SJ, Hwang SG, et al. Non-steroidal anti-inflammatory drugs inhibit nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes independent of cyclooxygenase activity. J Biol Chem 278:15319-15325, 2003. - PubMed -
59. Pelletier JP, Lajeunesse D, Jovanovic DV, et al. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis. J Rheumatol 27:2893-2902, 2000.
60. Budsberg SC, Johnston SA, Schwarz PD, et al. Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs. J Am Vet Med Assoc 214:206-210, 1999. - PubMed -
61. Cross AR, Budsberg SC, Keefe TJ. Kinetic gait analysis assessment of meloxicam efficacy in a sodium urate-induced synovitis model in dogs. Am J Vet Res 58:626-631, 1997. - PubMed -
62. Borer LR, Peel JE, Seewald W, et al. Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis. Am J Vet Res 64:1429-1437, 2003. - PubMed -
63. McLaughlin R. Management of chronic osteoarthritic pain. Vet Clin North Am Small Anim Pract 30:933-949, ix, 2000. - PubMed -
64. Boothe DM. Balancing fact and fiction of novel ingredients: definitions, regulations and evaluation. Vet Clin North Am Small Anim Pract 34:7-38, 2004. - PubMed -
65. de Haan JJ, Goring RL, Beale BS. Evaluation of polysulfated glycosaminoglycan for the treatment of hip dysplasia in dogs. Vet Surg 23:177-181, 1994. - PubMed -
66. Todhunter RJ, Lust G. Polysulfated glycosaminoglycan in the treatment of osteoarthritis. J Am Vet Med Assoc 204:1245-1251, 1994.
67. Lust G, Williams AJ, Burton-Wurster N, et al. Effects of intramuscular administration of glycosaminoglycan polysulfates on signs of incipient hip dysplasia in growing pups. Am J Vet Res 53:1836-1843, 1992. - PubMed -
68. Budsberg S. Proceedings of Veterinary Orthopedic Society Abstract, March 2005.
69. Adabowale A, Cox DS, Liang Z, et al. Analysis of glucosamine and chondroitin sulfate content in marketed products and the caco-2 permeability of chondroitin sulfate raw materials. Am Nutraceut Assoc :37-44, 2000.
70. Russell AS, Aghazadeh-Habashi A, Jamali F. Active ingredient consistency of commercially available glucosamine sulfate products. J Rheumatol 29:2407-2409, 2002.
71. Adebowale A, Du J, Liang Z, et al. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm Drug Dispos 23:217-225, 2002.
72. Chan PS, Caron JP, Orth MW. Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants. Am J Vet Res 66:1870-1876, 2005. - PubMed -
73. McNamara PS, Barr SC, Erb HN. Hematologic, hemostatic, and biochemical effects in dogs receiving an oral chondroprotective agent for thirty days. Am J Vet Res 57:1390-1394, 1996. - PubMed -
74. McNamara PS, Barr SC, Erb HN, Barlow LL. Hematologic, hemostatic, and biochemical effects in cats receiving an oral chondroprotective agent for thirty days. Vet Ther 1:108-117, 2000. - PubMed -
75. Moreau M, Dupuis J, Bonneau NH, et al. Clinical evaluation of a powder of quality elk velvet antler for the treatment of osteoarthrosis in dogs. Can Vet J 45:133-139, 2004. - PubMed -
76. Deparle LA, Gupta RC, Canerdy TD, et al. Efficacy and safety of glycosylated undenatured type-II collagen (UC-II) in therapy of arthritic dogs. J Vet Pharmacol Ther 28:385-390, 2005. - PubMed -
77. Gingerich DA, Strobel JD. Use of client-specific outcome measures to assess treatment effects in geriatric, arthritic dogs: controlled clinical evaluation of a nutraceutical. Vet Ther 4:56-66, 2003. - PubMed -
78. Bui LM, Bierer TL. Influence of green lipped mussels (Perna canaliculus) in alleviating signs of arthritis in dogs. Vet Ther 4:397-407, 2003. - PubMed -
79. Todhunter RJ, Lust G. Osteoarthritis. In: Textbook of Small Animal Surgery. Slatter D (ed). Philadelphia: WB Saunders, 2003.